Integrin β6 mediates epithelial-mesenchymal transition in diabetic kidney disease

Mol Cell Endocrinol. 2023 Jul 15:572:111955. doi: 10.1016/j.mce.2023.111955. Epub 2023 May 13.

Abstract

The progression of diabetic kidney disease (DKD) is associated with increased fibronectin (FN) levels in proximal tubular epithelial cells. Bioinformatics analysis showed that integrin β6 and cell adhesion function were significantly changed in the cortices of db/db mice. Remodelling of cell adhesion is one of the core changes during epithelial-mesenchymal transition (EMT) in DKD. Integrin is a family of transmembrane proteins that regulates cell adhesion and migration, and extracellular FN is the major ligand of integrin β6. We found that the expression of integrin β6 was elevated in the proximal tubules of db/db mice and FN-induced renal proximal tubule cells. The levels of EMT were also significantly increased in vivo and in vitro. In addition, FN treatment activated the Fak/Src pathway, increased the expression of p-YAP, and then upregulated the Notch1 pathway in diabetic proximal tubules. Knockdown of integrin β6 or Notch1 reduced the EMT aggravation induced by FN. Furthermore, urinary integrin β6 was significantly increased in DKD patients. Our findings reveal a critical role of integrin β6 in regulating EMT in proximal tubular epithelial cells and identify a novel direction for the detection and treatment of DKD.

Keywords: Diabetic kidney disease; Epithelial–mesenchymal transition; Integrin β6; Notch1; YAP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus*
  • Diabetic Nephropathies* / metabolism
  • Epithelial-Mesenchymal Transition
  • Integrin beta Chains / metabolism
  • Mice
  • Signal Transduction / physiology

Substances

  • integrin beta6
  • Integrin beta Chains